Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2010, Article ID 192543, 8 pages
http://dx.doi.org/10.1155/2010/192543
Review Article

Toll-Like Receptor Signaling and Liver Fibrosis

1Division of Gastroenterology, Department of Medicine, School of Medicine, University of California San Diego, 9500 Gilman Drive MC# 0702, Leichtag Biomedical Research Building Rm# 332 MM, La Jolla, CA 92093-0702, USA
2Department of Internal Medicine, College of Medicine, Yonsei University, Seoul 135-720, Republic of Korea

Received 24 March 2010; Accepted 16 June 2010

Academic Editor: Ian Nicholas Crispe

Copyright © 2010 Tomonori Aoyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Bataller and D. A. Brenner, “Liver fibrosis,” Journal of Clinical Investigation, vol. 115, no. 2, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Friedman, “Mechanisms of hepatic fibrogenesis,” Gastroenterology, vol. 134, no. 6, pp. 1655–1669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. R.-S. Lin, F.-Y. Lee, S.-D. Lee et al., “Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation,” Journal of Hepatology, vol. 22, no. 2, pp. 165–172, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. C. C. Chan, S. J. Hwang, F. Y. Lee et al., “Prognostic value of plasma endotoxin levels in patients with cirrhosis,” Scandinavian Journal of Gastroenterology, vol. 32, no. 9, pp. 942–946, 1997. View at Google Scholar · View at Scopus
  5. K. Takeda and S. Akira, “Toll-like receptors in innate immunity,” International Immunology, vol. 17, no. 1, pp. 1–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Seki, H. Tsutsui, H. Nakano et al., “Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β,” Journal of Immunology, vol. 166, no. 4, pp. 2651–2657, 2001. View at Google Scholar · View at Scopus
  7. E. Seki and D. A. Brenner, “Toll-like receptors and adaptor molecules in liver disease: update,” Hepatology, vol. 48, no. 1, pp. 322–335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Szabo, A. Dolganiuc, and P. Mandrekar, “Pattern recognition receptors: a contemporary view on liver diseases,” Hepatology, vol. 44, no. 2, pp. 287–298, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-H. Paik, R. F. Schwabe, R. Bataller, M. P. Russo, C. Jobin, and D. A. Brenner, “Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells,” Hepatology, vol. 37, no. 5, pp. 1043–1055, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Seki, S. De Minicis, C. H. Österreicher et al., “TLR4 enhances TGF-β signaling and hepatic fibrosis,” Nature Medicine, vol. 13, no. 11, pp. 1324–1332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. I. N. Crispe, “The liver as a lymphoid organ,” Annual Review of Immunology, vol. 27, pp. 147–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. I. N. Crispe, “Hepatic T cells and liver tolerance,” Nature Reviews Immunology, vol. 3, no. 1, pp. 51–62, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Onichtchouk, Y.-G. Chen, R. Dosch et al., “Silencing of TGF-β signalling by the pseudoreceptor BAMBI,” Nature, vol. 401, no. 6752, pp. 480–485, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Wang, M. Trippler, R. Pei et al., “Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication,” Journal of Hepatology, vol. 51, pp. 1037–1045, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-H. Paik, K. S. Lee, H. J. Lee et al., “Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid,” Laboratory Investigation, vol. 86, no. 7, pp. 676–686, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Watanabe, A. Hashmi, D. A. Gomes et al., “Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9,” Hepatology, vol. 46, no. 5, pp. 1509–1518, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Isayama, I. N. Hines, M. Kremer et al., “LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 290, no. 6, pp. G1318–G1328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. Nolan and A. I. Leibowitz, “Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin b—an antiendotoxin,” Gastroenterology, vol. 75, no. 3, pp. 445–449, 1978. View at Google Scholar · View at Scopus
  20. I. Grinko, A. Geerts, and E. Wisse, “Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia,” Journal of Hepatology, vol. 23, no. 4, pp. 449–458, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov, “Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis,” Cell, vol. 118, no. 2, pp. 229–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Tsung, R. Sahai, H. Tanaka et al., “The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion,” Journal of Experimental Medicine, vol. 201, no. 7, pp. 1135–1143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. F. Schwabe, E. Seki, and D. A. Brenner, “Toll-like receptor signaling in the liver,” Gastroenterology, vol. 130, no. 6, pp. 1886–1900, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Klein, J. C. Cornejo, N. K. Polakos et al., “Kupffer cell heterogeneity: functional properties of bone marrow-derived and sessile hepatic macrophages,” Blood, vol. 110, no. 12, pp. 4077–4085, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. D. W. Kennedy and J. L. Abkowitz, “Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model,” Blood, vol. 90, no. 3, pp. 986–993, 1997. View at Google Scholar · View at Scopus
  26. M. Isogawa, M. D. Robek, Y. Furuichi, and F. V. Chisari, “Toll-like receptor signaling inhibits hepatitis B virus replication in vivo,” Journal of Virology, vol. 79, no. 11, pp. 7269–7272, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Kisseleva, H. Uchinami, N. Feirt et al., “Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis,” Journal of Hepatology, vol. 45, no. 3, pp. 429–438, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Higashiyama, T. Moro, S. Nakao et al., “Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice,” Gastroenterology, vol. 137, no. 4, pp. 1459–1466, 2009, e1451. View at Publisher · View at Google Scholar · View at Scopus
  29. S. T. Magness, R. Bataller, L. Yang, and D. A. Brenner, “A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations,” Hepatology, vol. 40, no. 5, pp. 1151–1159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Yan, Z. Lin, F. Chen et al., “Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-β signaling,” Journal of Biological Chemistry, vol. 284, no. 44, pp. 30097–30104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Harada, Y. Sato, H. Ikeda et al., “Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia,” Journal of Pathology, vol. 217, no. 5, pp. 654–664, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Huang, M. L. Shiffman, S. Friedman et al., “A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C,” Hepatology, vol. 46, no. 2, pp. 297–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Li, M. Chang, O. Abar et al., “Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection,” Journal of Hepatology, vol. 51, no. 4, pp. 750–757, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. N. C. Arbour, E. Lorenz, B. C. Schutte et al., “TLR4 mutations are associated with endotoxin hyporesponsiveness in humans,” Nature Genetics, vol. 25, no. 2, pp. 187–191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Guo, J. Loke, F. Zheng et al., “Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of toll-like receptor 4 to hepatic stellate cell responses,” Hepatology, vol. 49, no. 3, pp. 960–968, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Radaeva, R. Sun, B. Jaruga, V. T. Nguyen, Z. Tian, and B. Gao, “Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners,” Gastroenterology, vol. 130, no. 2, pp. 435–452, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Jeong, O. Park, and B. Gao, “Abrogation of the antifibrotic effects of natural killer cells/interferon-γ contributes to alcohol acceleration of liver fibrosis,” Gastroenterology, vol. 134, no. 1, pp. 248–258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Francés, S. Benlloch, P. Zapater et al., “A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites,” Hepatology, vol. 39, no. 2, pp. 484–491, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Guarner, J. M. González-Navajas, E. Sánchez et al., “The detection of bacterial DNA in blood of rats with CCl 4-induced cirrhosis with ascites represents episodes of bacterial translocation,” Hepatology, vol. 44, no. 3, pp. 633–639, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Gäbele, M. Mühlbauer, C. Dorn et al., “Role of TLR9 in hepatic stellate cells and experimental liver fibrosis,” Biochemical and Biophysical Research Communications, vol. 376, no. 2, pp. 271–276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. K. Connolly, A. S. Bedrosian, J. Mallen-St. Clair et al., “In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-α,” Journal of Clinical Investigation, vol. 119, no. 11, pp. 3213–3225, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Aloman and F. Tacke, “Dendritic cells in liver fibrosis: conductor of the inflammatory orchestra?” Hepatology, vol. 51, no. 3, pp. 1070–1072, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. J.-H. Shim, C. Xiao, A. E. Paschal et al., “TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo,” Genes and Development, vol. 19, no. 22, pp. 2668–2681, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Sato, H. Sanjo, K. Takeda et al., “Essential function for the kinase TAK1 in innate and adaptive immune responses,” Nature Immunology, vol. 6, no. 11, pp. 1087–1095, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. R. F. Schwabe and D. A. Brenner, “Mechanisms of liver injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 290, no. 4, pp. G583–G589, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Chang, H. Kamata, G. Solinas et al., “The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIPL turnover,” Cell, vol. 124, no. 3, pp. 601–613, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Inokuchi, T. Aoyama, K. Miura et al., “Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 2, pp. 844–849, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Bettermann, M. Vucur, J. Haybaeck et al., “TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer,” Cancer Cell, vol. 17, no. 5, pp. 481–496, 2010. View at Google Scholar
  49. Q. Zhang, M. Raoof, Y. Chen et al., “Circulating mitochondrial DAMPs cause inflammatory responses to injury,” Nature, vol. 464, no. 1, pp. 104–107, 2010. View at Publisher · View at Google Scholar · View at Scopus